Suzuki Rei 鈴木玲

Researcher Number	80590546
Other IDs
Affiliation (Current)	2025: 福島県立医科大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2020 – 2023: 福島県立医科大学, 医学部, 助教 2016: 福島県立医科大学, 医学部, 助手 2015 – 2016: 福島県立医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor diagnostics
Keywords	Principal Investigator 膵癌 / 免疫回避機構 / 補体系 / 腫瘍免疫 / がん微小環境 / C3a受容体 / 補体 / 化学療法 / 線維化 / 間質 / 抗がん薬 / digital PCR / microRNA

Research Projects
(3 results)
Research Products
(7 results)

The role of C3AR expression in anti-tumor immunityPrincipal Investigator
- Principal Investigator
  
  鈴木玲
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Fukushima Medical University
Mechanisms of Antibody Drug Resistance in Pancreatic Cancer: Focus on Complement Regulatory Proteins.Principal Investigator
- Principal Investigator
  
  Suzuki Rei
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Fukushima Medical University
Digital PCR quantification of fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinomaPrincipal Investigator
- Principal Investigator
  
  Suzuki Rei
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor diagnostics
- Research Institution
  Fukushima Medical University

All 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] Clinical benefit of subsequent chemotherapy after drug-i３nduced interstitial lung disease in pancreatic cancer patients: a multicenter retrospective study from Japan2023
- Author(s)
  Irie Hiroki、Suzuki Rei、Okubo Yoshinori、Asama Hiroyuki、Konno Naoki、Noguchi Yuki、Watanabe Ko、Shibukawa Goro、Imamura Hidemichi、Takagi Tadayuki、Sugimoto Mitsuru、Sato Yuki、Nakamura Jun、Kato Tsunetaka、Hashimoto Minami、Yanagita Takumi、Hikichi Takuto、Ohira Hiromasa
- Journal Title
  
  BMC Cancer
  
  Volume: 23 Issue: 1 Pages: 316-316
- DOI
  10.1186/s12885-023-10781-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16419
[Journal Article] Intracellular C3 Modulates EMT<i>via</i>the Akt/Smad Pathway in Pancreatic Cancer Cells2022
- Author(s)
  SUZUKI REI、TAKAGI TADAYUKI、SUGIMOTO MITSURU、SATO YUKI、IRIE HIROKI、YOMOGIDA YUKI、OHIRA HIROMASA
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 12 Pages: 5743-5750
- DOI
  10.21873/anticanres.16081
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16419
[Journal Article] The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma2022
- Author(s)
  SUZUKI REI、OKUBO YOSHINORI、TAKAGI TADAYUKI、SUGIMOTO MITSURU、SATO YUKI、IRIE HIROKI、NAKAMURA JUN、TAKASUMI MIKA、KATO TSUNETAKA、HASHIMOTO MINAMI、KOBASHI RYOUICHIRO、HIKICHI TAKUTO、OHIRA HIROMASA
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 3 Pages: 1207-1215
- DOI
  10.21873/anticanres.15587
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16419
[Presentation] 膵癌免疫回避機構における補体C3受容体C3ARの役割2023
- Author(s)
  鈴木　玲、高木忠之、大平弘正
- Organizer
  第109回　日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-20K16419
[Presentation] 膵癌細胞内補体 C3 の意義に関する検討2021
- Author(s)
  鈴木　玲
- Organizer
  第52回　日本膵臓学会
- Data Source
  KAKENHI-PROJECT-20K16419
[Presentation] 補体C3a/C3aR axisはMAPK/Erk signaling pathwayを介して膵癌上皮間葉転換を制御する2021
- Author(s)
  鈴木　玲
- Organizer
  第63回　日本消化器病学会
- Data Source
  KAKENHI-PROJECT-20K16419
[Presentation] 膵癌微小環境における補体C3aの働きに関する検討2020
- Author(s)
  鈴木　玲、高木忠之、大平弘正
- Organizer
  第62回日本消化器病学会大会
- Data Source
  KAKENHI-PROJECT-20K16419

Suzuki Rei 鈴木 玲

Research Projects

Research Products

The role of C3AR expression in anti-tumor immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanisms of Antibody Drug Resistance in Pancreatic Cancer: Focus on Complement Regulatory Proteins.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Digital PCR quantification of fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Clinical benefit of subsequent chemotherapy after drug-i３nduced interstitial lung disease in pancreatic cancer patients: a multicenter retrospective study from Japan2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Intracellular C3 Modulates EMT<i>via</i>the Akt/Smad Pathway in Pancreatic Cancer Cells2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Presentation] 膵癌免疫回避機構における補体C3受容体C3ARの役割2023

Author(s)

Organizer

Data Source

[Presentation] 膵癌細胞内補体 C3 の意義に関する検討2021

Author(s)

Organizer

Data Source

[Presentation] 補体C3a/C3aR axisはMAPK/Erk signaling pathwayを介して膵癌上皮間葉転換を制御する2021

Author(s)

Organizer

Data Source

[Presentation] 膵癌微小環境における補体C3aの働きに関する検討2020

Author(s)

Organizer

Data Source

Suzuki Rei 鈴木玲